About John Sorensen
John Sorensen is a president and director at Esanik Therapeutics.
John Sorensen first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Sorensen in the role, so the role may have started earlier or lasted longer.
Esanik Therapeutics, Inc.
President and director
2024 – 2026 · Northville, MI
Develops a treatment for people with prostate cancer.